These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 33371070)

  • 1. Diagnostic value of microRNA-25 in patients with non-small cell lung cancer in Chinese population: A systematic review and meta-analysis.
    Li C; Sun L; Zhou H; Yang Y; Wang Y; She M; Chen J
    Medicine (Baltimore); 2020 Dec; 99(51):e23425. PubMed ID: 33371070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of diagnostic and prognostic value of miR-126 in non-small cell lung cancer.
    Sun L; Zhou H; Yang Y; Chen J; Wang Y; She M; Li C
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32329507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic value of microRNA-148/152 family in non-small-cell lung cancer (NSCLC): A systematic review and meta-analysis.
    Cheng L; Li Q; Tan B; Ma D; Du G
    Medicine (Baltimore); 2021 Dec; 100(48):e28061. PubMed ID: 35049226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical use of microRNAs as potential non-invasive biomarkers for detecting non-small cell lung cancer: a meta-analysis.
    Wang H; Wu S; Zhao L; Zhao J; Liu J; Wang Z
    Respirology; 2015 Jan; 20(1):56-65. PubMed ID: 25440223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review and meta-analysis of the diagnostic value of circulating microRNA-17-5p in patients with non-small cell lung cancer.
    Hao J; Shen Z
    Medicine (Baltimore); 2023 Feb; 102(8):e33070. PubMed ID: 36827064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-145 as a diagnostic biomarker for non-small-cell lung cancer: A systemic review and meta-analysis.
    Tao S; Ju X; Zhou H; Zeng Q
    Int J Biol Markers; 2020 Dec; 35(4):51-60. PubMed ID: 33103527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P16
    Tuo L; Sha S; Huayu Z; Du K
    Thorac Cancer; 2018 Aug; 9(8):1032-1040. PubMed ID: 29927090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs in sputum specimen as noninvasive biomarkers for the diagnosis of nonsmall cell lung cancer: An updated meta-analysis.
    Zhang X; Wang Q; Zhang S
    Medicine (Baltimore); 2019 Feb; 98(6):e14337. PubMed ID: 30732158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.
    Zhu W; Zhou K; Zha Y; Chen D; He J; Ma H; Liu X; Le H; Zhang Y
    PLoS One; 2016; 11(4):e0153046. PubMed ID: 27093275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of serum Cyfra21-1 as a biomarker in the diagnosis of patients with non-small cell lung cancer: a meta-analysis.
    Cui C; Sun X; Zhang J; Han D; Gu J
    J Cancer Res Ther; 2014 Nov; 10 Suppl():C131-4. PubMed ID: 25450270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in body fluids as biomarkers for non-small cell lung cancer: a systematic review.
    Huang Y; Hu Q; Deng Z; Hang Y; Wang J; Wang K
    Technol Cancer Res Treat; 2014 Jun; 13(3):277-87. PubMed ID: 24066954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis.
    Huang H; Zhu J; Lin Y; Zhang Z; Liu J; Wang C; Wu H; Zou T
    Expert Rev Mol Diagn; 2021 Aug; 21(8):823-836. PubMed ID: 34043929
    [No Abstract]   [Full Text] [Related]  

  • 13. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer.
    Yi M; Liao Z; Deng L; Xu L; Tan Y; Liu K; Chen Z; Zhang Y
    Ann Med; 2021 Dec; 53(1):2178-2193. PubMed ID: 34913774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer.
    Wang RJ; Zheng YH; Wang P; Zhang JZ
    Int J Clin Exp Pathol; 2015; 8(1):765-71. PubMed ID: 25755772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential circulating miRNA signature for early detection of NSCLC.
    Arab A; Karimipoor M; Irani S; Kiani A; Zeinali S; Tafsiri E; Sheikhy K
    Cancer Genet; 2017 Oct; 216-217():150-158. PubMed ID: 29025589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs as novel biomarkers in the diagnosis of non-small cell lung cancer: a meta-analysis based on 20 studies.
    Chen L; Jin H
    Tumour Biol; 2014 Sep; 35(9):9119-29. PubMed ID: 25027397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of miR-200 family in non-small cell lung cancer: a meta-analysis.
    Ling Z; Yang L
    Biomark Med; 2024; 18(8):419-431. PubMed ID: 39041844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.
    He X; Chi Y; Peng J; Hu W; Ding C; Li B
    J Thorac Dis; 2022 Jun; 14(6):2103-2111. PubMed ID: 35813759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low plasma miR-25 expression is a favorite prognosis factor in non-small cell lung cancer.
    Zhang YL; Zhang ZL; Zhu XB; Xu L; Lu P; Xu M; Liu WJ; Zhang XY; Yao HM; Ye XW
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5251-5259. PubMed ID: 31298376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.